Triple
T22692932
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | FIREFISH |
E561096
|
entity |
| Predicate | developedWith |
P12687
|
FINISHED |
| Object | PTC Therapeutics |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: PTC Therapeutics | Statement: [FIREFISH, developedWith, PTC Therapeutics]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: PTC Therapeutics Context triple: [FIREFISH, developedWith, PTC Therapeutics]
-
A.
PTC Therapeutics
chosen
PTC Therapeutics is a biopharmaceutical company focused on developing small-molecule and RNA-based therapies for rare genetic disorders and other serious diseases.
-
B.
PTC Inc.
PTC Inc. is an American software company best known for its computer-aided design (CAD), product lifecycle management (PLM), and industrial Internet of Things (IIoT) solutions for manufacturing and engineering.
-
C.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is a biotechnology company best known for developing transformative therapies for cystic fibrosis and other serious diseases using a precision medicine approach.
-
D.
Cubist Pharmaceuticals
Cubist Pharmaceuticals was a biopharmaceutical company best known for developing and commercializing antibiotics to treat serious and drug-resistant infections.
-
E.
Portola Pharmaceuticals
Portola Pharmaceuticals is a biopharmaceutical company specializing in the development of therapies for thrombosis and other hematologic conditions.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
| NER | Named-entity recognition | batch_69f1789ba0148190891781d05ec64f3c |
completed | April 29, 2026, 3:18 a.m. |
Created at: April 17, 2026, 3:13 p.m.